Anupam Rasayan India Limited
NSE: ANURAS · Specialty Chemicals
Snapshot
Unlock Anupam Rasayan India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Anupam Rasayan India Limited specialises in the custom synthesis and manufacturing of specialty chemicals for the life sciences and other industrial sectors. Its product portfolio includes agrochemical intermediates, personal care ingredients, and key starting materials for active pharmaceutical ingredients.
Business Model
The company operates on a custom synthesis and manufacturing model, providing tailored chemical solutions to global and domestic clients. Revenue is generated through the production of complex chemical intermediates and active ingredients for diverse end-user industries.
Growth Outlook
Growth is driven by the expansion of its custom synthesis capabilities and increasing demand for specialised chemical intermediates in the agrochemical and pharmaceutical sectors. The company continues to leverage its manufacturing infrastructure to cater to both domestic and international markets.
Key Risks
- Regulatory and Environmental Compliance. The specialty chemicals sector is subject to stringent environmental regulations and safety standards that may impact operational costs.
- Client Concentration Risk. Dependence on a limited number of large-scale customers in the agrochemical and pharmaceutical industries could affect revenue stability.
- Raw Material Price Volatility. Fluctuations in the prices of key chemical feedstocks and petrochemical derivatives can significantly impact profit margins.
- Geopolitical and Export Risks. As an exporter, the company is exposed to international trade barriers, currency fluctuations, and geopolitical instability in key markets.
Start your research today
Unlock AI insights, financials, peers and live data on Anupam Rasayan India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,535 Cr
TTM · consolidated
NET PROFIT
₹225 Cr
TTM · consolidated
EPS
₹15.38
TTM · consolidated
RETURN ON EQUITY
7.3%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.6%
TTM · consolidated
P/E
80.5x
Q1 FY27 · consolidated
EV/EBITDA
26.4x
Q1 FY27 · consolidated
EBITDA MARGIN
23.2%
TTM · consolidated
NET PROFIT MARGIN
7.8%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.5x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Anupam Rasayan India LimitedANURAS | ₹14,102 Cr | 80.54 | 26.39 | 51.8% | 23.2% | 7.3% | 9.6% | +12.4% |
BASF India Ltd.BASF | ₹16,729 Cr | 25.99 | 15.53 | 6.7% | 6.3% | 16.9% | 21.0% | -16.8% |
Fine Organic Industries LimitedFINEORG | ₹15,796 Cr | 36.06 | 24.59 | 7.3% | 25.7% | 17.7% | 23.0% | +5.9% |
Vinati Organics LimitedVINATIORGA | ₹13,587 Cr | 30.30 | 18.89 | 5.1% | 30.2% | 15.1% | 19.0% | -24.2% |
Privi Speciality Chemicals LimitedPRIVISCL | ₹13,154 Cr | 37.60 | 20.41 | 21.6% | 25.9% | 27.2% | 29.1% | +50.7% |
Jubilant Ingrevia Ltd.JUBLINGREA | ₹10,836 Cr | 34.82 | 17.24 | 11.0% | 14.3% | 10.2% | 12.4% | -7.0% |
As of Q1 FY27
Financials
Anupam Rasayan India Limited
NSE: ANURAS · Specialty Chemicals
Snapshot
Unlock Anupam Rasayan India Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Anupam Rasayan India Limited specialises in the custom synthesis and manufacturing of specialty chemicals for the life sciences and other industrial sectors. Its product portfolio includes agrochemical intermediates, personal care ingredients, and key starting materials for active pharmaceutical ingredients.
Business Model
The company operates on a custom synthesis and manufacturing model, providing tailored chemical solutions to global and domestic clients. Revenue is generated through the production of complex chemical intermediates and active ingredients for diverse end-user industries.
Growth Outlook
Growth is driven by the expansion of its custom synthesis capabilities and increasing demand for specialised chemical intermediates in the agrochemical and pharmaceutical sectors. The company continues to leverage its manufacturing infrastructure to cater to both domestic and international markets.
Key Risks
- Regulatory and Environmental Compliance. The specialty chemicals sector is subject to stringent environmental regulations and safety standards that may impact operational costs.
- Client Concentration Risk. Dependence on a limited number of large-scale customers in the agrochemical and pharmaceutical industries could affect revenue stability.
- Raw Material Price Volatility. Fluctuations in the prices of key chemical feedstocks and petrochemical derivatives can significantly impact profit margins.
- Geopolitical and Export Risks. As an exporter, the company is exposed to international trade barriers, currency fluctuations, and geopolitical instability in key markets.
Start your research today
Unlock AI insights, financials, peers and live data on Anupam Rasayan India Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,535 Cr
TTM · consolidated
NET PROFIT
₹225 Cr
TTM · consolidated
EPS
₹15.38
TTM · consolidated
RETURN ON EQUITY
7.3%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.6%
TTM · consolidated
P/E
80.5x
Q1 FY27 · consolidated
EV/EBITDA
26.4x
Q1 FY27 · consolidated
EBITDA MARGIN
23.2%
TTM · consolidated
NET PROFIT MARGIN
7.8%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.5x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27